{"id":"https://openalex.org/W4392702252","doi":"https://doi.org/10.1158/2159-8290.c.6545775.v1","title":"Data from Cell-Selective Inhibition of NF-\u03baB Signaling Improves Therapeutic Index in a Melanoma Chemotherapy Model","display_name":"Data from Cell-Selective Inhibition of NF-\u03baB Signaling Improves Therapeutic Index in a Melanoma Chemotherapy Model","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4392702252","doi":"https://doi.org/10.1158/2159-8290.c.6545775.v1"},"language":"en","primary_location":{"id":"doi:10.1158/2159-8290.c.6545775.v1","doi":"https://doi.org/10.1158/2159-8290.c.6545775.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2159-8290.c.6545775.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/2159-8290.c.6545775.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088300643","display_name":"Thomas Enzler","orcid":"https://orcid.org/0000-0002-8775-1493","observed_orcids":["https://orcid.org/0000-0002-8775-1493","https://orcid.org/0000-0001-9838-9357"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Enzler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056028875","display_name":"Yasuyo Sano","orcid":"https://orcid.org/0000-0001-7024-0833","observed_orcids":["https://orcid.org/0000-0001-7024-0833"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yasuyo Sano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054654298","display_name":"Min\u2010Kyung Choo","orcid":"https://orcid.org/0000-0003-1492-7539","observed_orcids":["https://orcid.org/0000-0003-1492-7539"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Min-Kyung Choo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051932585","display_name":"Howard Brinkerhoff Cottam","orcid":"https://orcid.org/0000-0001-7382-0585","observed_orcids":["https://orcid.org/0000-0001-7382-0585"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Howard B. Cottam","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056315342","display_name":"Michael Karin","orcid":"https://orcid.org/0000-0002-2758-6473","observed_orcids":["https://orcid.org/0000-0002-2758-6473"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Karin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017303827","display_name":"Hensin Tsao","orcid":"https://orcid.org/0000-0002-2204-2071","observed_orcids":["https://orcid.org/0000-0002-2204-2071"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hensin Tsao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5037534545","display_name":"Jin Mo Park","orcid":"https://orcid.org/0000-0002-3458-5583","observed_orcids":["https://orcid.org/0000-0002-3458-5583"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jin Mo Park","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11591","display_name":"NF-\u03baB Signaling Pathways","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11591","display_name":"NF-\u03baB Signaling Pathways","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12620","display_name":"Signaling Pathways in Disease","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.9980000257492065},{"id":"https://openalex.org/keywords/ikappab-kinase-inhibition","display_name":"I\u03baB kinase inhibition","score":0.8619999885559082},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9779999852180481},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.972000002861023},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.8169999718666077},{"id":"https://openalex.org/keywords/host-toxicity","display_name":"host toxicity","score":0.8270000219345093},{"id":"https://openalex.org/keywords/myeloid-cells","display_name":"myeloid cells","score":0.8650000095367432},{"id":"https://openalex.org/keywords/neutrophils","display_name":"neutrophils","score":0.8460000157356262},{"id":"https://openalex.org/keywords/interleukin-1beta","display_name":"IL-1\u03b2","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tumor-necrosis","display_name":"tumor necrosis","score":0.6389999985694885},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.5730000138282776},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.6320000290870667},{"id":"https://openalex.org/keywords/therapeutic-index","display_name":"therapeutic index","score":0.796999990940094}],"concepts":[{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6131822466850281},{"id":"https://openalex.org/C2777382242","wikidata":"https://www.wikidata.org/wiki/Q6017816","display_name":"Index (typography)","level":2,"score":0.5848304629325867},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5598005652427673},{"id":"https://openalex.org/C2777730290","wikidata":"https://www.wikidata.org/wiki/Q411114","display_name":"NF-\u03baB","level":3,"score":0.5214595198631287},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.4531479477882385},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.43193376064300537},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38468775153160095},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.34707513451576233},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.30928242206573486},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.2521268129348755},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1938929259777069},{"id":"https://openalex.org/C136764020","wikidata":"https://www.wikidata.org/wiki/Q466","display_name":"World Wide Web","level":1,"score":0.11255195736885071},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10489121079444885}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2159-8290.c.6545775.v1","doi":"https://doi.org/10.1158/2159-8290.c.6545775.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2159-8290.c.6545775.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2159-8290.c.6545775.v1","doi":"https://doi.org/10.1158/2159-8290.c.6545775.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2159-8290.c.6545775.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9919999837875366,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2143428408","https://openalex.org/W1566305484","https://openalex.org/W2991480506","https://openalex.org/W7048126904","https://openalex.org/W2515644696","https://openalex.org/W2053634917","https://openalex.org/W1985036347","https://openalex.org/W7099144538","https://openalex.org/W2531926595","https://openalex.org/W2210321424"],"abstract_inverted_index":{"Abstract":[0],"The":[1],"transcription":[2],"factor":[3],"NF-\u03baB":[4,24,69,87,107],"promotes":[5],"the":[6,54,149,158,178,207,223],"survival":[7],"of":[8,85,106,115],"cancer":[9,175],"cells":[10,76],"exposed":[11],"to":[12,44,110,194],"doxorubicin":[13,47],"and":[14,26,73,80,118,170,188,214],"other":[15],"chemotherapeutic":[16],"agents.":[17],"I\u03baB":[18,35,159],"kinase":[19,36],"is":[20,163,220],"essential":[21],"for":[22,31,78,165],"chemotherapy-induced":[23],"activation":[25,70,108],"considered":[27],"a":[28,111,122,136],"prime":[29],"target":[30],"anticancer":[32],"treatment.":[33],"An":[34],"inhibitor":[37],"sensitized":[38],"human":[39],"melanoma":[40,72],"xenografts":[41],"in":[42,53,71,90,101,174,222],"mice":[43,102],"killing":[45],"by":[46,132,183,212],"yet":[48],"also":[49],"exacerbated":[50],"treatment":[51,95,168],"toxicity":[52,173],"host":[55,74,127,172],"animals.":[56],"By":[57,98],"using":[58],"mouse":[59],"models":[60],"that":[61,67,157],"simulate":[62],"cell-selective":[63],"targeting,":[64],"we":[65],"found":[66],"impaired":[68],"myeloid":[75],"accounts":[77],"therapeutic":[79,198],"adverse":[81],"effects,":[82],"respectively.":[83],"Ablation":[84],"tumor-intrinsic":[86],"activity":[88],"resulted":[89],"apoptosis-driven":[91],"tumor":[92,120,133],"regression":[93],"after":[94],"with":[96,103,125],"doxorubicin.":[97],"contrast,":[99],"chemotherapy":[100],"myeloid-specific":[104],"loss":[105],"led":[109],"massive":[112],"intratumoral":[113],"recruitment":[114],"interleukin-1\u03b2\u2013producing":[116],"neutrophils":[117],"necrotic":[119],"lesions,":[121],"condition":[123],"associated":[124],"increased":[126],"mortality":[128],"but":[129],"not":[130],"accompanied":[131],"regression.":[134],"Therefore,":[135],"molecular":[137],"target-based":[138],"therapy":[139],"may":[140],"be":[141,191],"steered":[142],"toward":[143],"different":[144],"clinical":[145],"outcomes":[146],"depending":[147],"on":[148,209],"drug's":[150],"cell-specific":[151],"effects.":[152],"Significance:":[153],"Our":[154],"findings":[155],"show":[156],"kinase\u2013NF-\u03baB":[160],"signaling":[161],"pathway":[162],"important":[164],"both":[166],"promoting":[167],"resistance":[169],"preventing":[171],"chemotherapy;":[176],"however,":[177],"two":[179],"functions":[180],"are":[181],"exerted":[182],"distinct":[184],"cell":[185],"type\u2013specific":[186],"mechanisms":[187],"can":[189],"therefore":[190],"selectively":[192],"targeted":[193],"achieve":[195],"an":[196],"improved":[197],"outcome.":[199],"Cancer":[200],"Discovery;":[201],"1(6);":[202],"496\u2013507.":[203],"\u00a92011":[204],"AACR.":[205],"Read":[206],"Commentary":[208],"this":[210],"article":[211,219],"Aggarwal":[213],"Sung,":[215],"p.":[216,228],"469":[217],"This":[218,225],"highlighted":[221],"In":[224],"Issue":[226],"feature,":[227],"457":[229]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2024-03-13T00:00:00"}